Global Expression Proteomics Market: Overview
Expression proteomics is the study of the dysregulated proteins formed as a result of stimulation or diseased condition. The global expression proteomics market is driven by the large-scale analysis of proteins and the limitation of bioinformatics to determine the existence of proteins and understand their functions. The need for identifying posttranslational modifications to understand protein functions to find drug targets and diagnostic markers has fuelled developments in expression proteomics. The crucial factors driving the evolution of the expression proteomics market are the large-scale accumulation of DNA and protein sequence databases, advancement in mass spectrometry, and wide use of various computer algorithms in database searching.
The demand for personalized therapies has fuelled the demand for the analysis of target proteins. The emergence of functional proteomics to provide information about protein signaling mechanisms and protein-drug interactions is gaining popularity. Coupled with this, advances in mass spectrometry and large-scale nucleotide sequencing of genomic DNA have greatly helped in the evolution of the market.
The report provides detailed analysis of the current market status, emerging trends, technological advancements, and revenue share of key product segments. The study highlights the key business practices adopted by players to consolidate their shares. The research analysis provides in-depth insights into the factors affecting the demand for leading segments in major regions such as North America, Asia Pacific, and Europe. Prominent developments such as delivery of personalized medicines expected to shape up the competitive landscape are carefully evaluated. The changes in regulatory landscape expected to affect the demand for expression proteomics in emerging markets are assessed in detail.
Global Expression Proteomics Market: Trends and Opportunities
The global market for expression proteomics is poised to grow at a steady pace along the forecast period. The market is primarily driven by the extensive researches in the pharmaceutical and biotechnology related to posttranslational modifications of proteins. Increased demand for personalized medicine, technological advancement in spectrometer technology, and rising applications of proteomics in targeted drug discovery are crucial factors propelling the growth of the expression proteomics market.
Prokaryotic expression in proteomics is a key segment. The remarkable growth in the segment is driven by the use of Escherichia Coli (E.Coli) as the mostly preferred used host cell since it is easily available. In addition, the protein expression using E.Coli is inexpensive. Among products, reagents contributes the maximum revenue and is driven by the demand of high-performing microarray reagents, immunoassays, and spectroscopy reagents. These reagents find extensive applications for a large number of transfections and maintenance of cell lines.
However, the high cost of tools used in proteomics researches, prolonged regulatory approvals in developed nations, and limited technical expertise are the factors likely to hinder the growth of the market. On the other hand, advances in nanotechnology, a large untapped market in emerging nations, and the demand for biomarker identification in disease diagnosis are expected to unlock lucrative avenues for market players.
Global Expression Proteomics Market: Regional Outlook
Currently, North America dominates the global expression proteomics market and is followed by Europe. The key factors propelling the expression proteomics market in these regions are continuous technological advancements in spectrometer and increased demand for the use of expression proteomics in developing personalized therapies. The Asia Pacific expression proteomics market is expected to witness impressive growth along the forecast period. The growth in the regional market is attributed to increasing government support and substantial private funding toward research and development in major countries such as India, Australia, Japan, and China.
Global Expression Proteomics Market: Competitive Landscape
Large market players are making substantial investment in large-scale accumulation of DNA and protein sequence databases while small players with constrained budget are partnering contract research organizations to launch new products. Major companies operating in this market include ActivX Biosciences, Inc., Life Technologies Corporation, Agilent Technologies, Inc., New England Biolabs, Inc., Takara Bio, Inc., QIAGEN, Bio-Rad Laboratories, Merck Millipore, Tyrian Diagnostics, Ltd., Hybrigenics SA, Promega Corporation, Luminex Corporation, Danaher Corporation, Sigma-Aldrich Corporation, and Thermo Fischer Scientific, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.